Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $21.74 USD
Change Today -0.01 / -0.05%
Volume 596.4K
MNTA On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

Earnings & Estimates Summary - MOMENTA PHARMACEUTICALS INC (MNTA)

Momenta Pharmaceuticals Inc. to Report Q2, 2015 on Aug 04, 2015
CapIQ 08/04/2015 1:00 PM ET
Momenta Pharmaceuticals Inc. to Report Q1, 2015 on May 01, 2015
CapIQ 08/04/2015 1:00 PM ET
Momenta Pharmaceuticals Inc. to Report Q4, 2014 on Feb 17, 2015
CapIQ 08/04/2015 1:00 PM ET

2013 revenues at Momenta Pharmaceuticals Inc. totaled $35.5M USD, while annual losses equaled $2.13 per share.

Quarterly Earnings & Estimates - MOMENTA PHARMACEUTICALS INC (MNTA)

Chart not available

Momenta Pharmaceuticals Inc.'s Quarterly Earnings

Momenta Pharmaceuticals Inc. reported 2nd quarter 2014 on 08/2/2014.

Annual Earnings & Estimates - MOMENTA PHARMACEUTICALS INC (MNTA)

Actuals vs. Estimates for MOMENTA PHARMACEUTICALS INC MNTA

Momenta Pharmaceuticals Inc.'s Annual Earnings

Momenta Pharmaceuticals Inc. reported annual 2013 losses of $2.13 per share on 02/12/2014.

Quarterly Revenues - MOMENTA PHARMACEUTICALS INC (MNTA)

Chart not available

Annual Revenues - MOMENTA PHARMACEUTICALS INC (MNTA)

Actuals vs. Estimates for MOMENTA PHARMACEUTICALS INC MNTA

Momenta Pharmaceuticals Inc.'s Annual Revenues

Momenta Pharmaceuticals Inc. had revenues for the full year 2013 of $35.5M USD. This was -44.5% below the prior year's results.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MNTA:US $21.74 USD -0.01

MNTA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Amarin Corp PLC $2.26 USD +0.06
Amphastar Pharmaceuticals Inc $16.26 USD +0.51
OraSure Technologies Inc $4.94 USD -0.12
SciClone Pharmaceuticals Inc $9.11 USD -0.10
Sucampo Pharmaceuticals Inc $21.79 USD +0.89
View Industry Companies
 

Industry Analysis

MNTA

Industry Average

Valuation MNTA Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 23.7x
Price/Book 5.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales 24.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MOMENTA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.